What We're Reading: Page 2
Industry reads hand-picked by our editors
May 13, 2026
-
MIT Technology Review
A plan to make drugs in orbit is going commercial
-
Nature
AI can design viruses, toxins and other bioweapons. How worried should we be?
-
The Atlantic
‘This Is Not Going to Be the Next COVID’
May 12, 2026
May 11, 2026
-
Axios
FDA cliffhanger: Will Marty Makary stay or go?
-
The Wall Street Journal
The Next Frontier for Hantavirus: Finding Vaccines and Treatments
-
The New York Times
What if You Could Give Your Dog a Longer Life?
May 08, 2026
May 07, 2026
-
Reuters
Novo and Lilly gain on signs weight-loss pills could expand the market
-
The Wall Street Journal
Inside the Global Effort to Figure Out Where Hantavirus Will Strike Next
-
The New York Times
American Factories Lag in Adopting A.I. This Drugmaker Is an Exception.
-
Stat
Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with review
May 06, 2026
May 05, 2026
-
Bloomberg
Paranoia, Turmoil and Backlash: Inside the FDA Under Marty Makary
-
The Wall Street Journal
The Quest to Use AI to Help Find New Drugs
-
The Washington Post
How Republicans came to embrace psychedelic drugs
Previous
